Asset Management One Co., Ltd. Sage Therapeutics, Inc. Transaction History

Asset Management One Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$54.88 - $79.29 $101,253 - $146,290	-1,845 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $130,349 - $178,522	1,845 New	1,845 $138,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $187,307 - $311,456	-7,218 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $574,627 - $778,076	4,096 Added 131.2%	7,218 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $492,807 - $571,606	3,122 New	3,122 $572,000

200

46.5M

462K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $319M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.